Latest Financial Position News

Moab Minerals has terminated its acquisition of the Sasare Cu-Au Project in Zambia and is now concentrating on advancing its Manyoni Uranium Project in Tanzania, buoyed by strong uranium prices and strategic tenement acquisitions.

Babylon Pump & Power has reported a robust December quarter, driven by strong rental segment performance and a significant new contract with Newmont. Despite challenges in its maintenance division, the company is positioned for growth with fresh leadership and strategic asset management.

Torque Metals reports significant high-grade gold discoveries extending beyond current resources at its Paris Gold Project, backed by a $15 million placement that leaves the company well-funded for aggressive drilling in 2026.

Bridge SaaS Limited reports steady operational progress in its disability services division, highlighted by the launch of a wholly owned NSW subsidiary and solid cash flow results for the December 2025 quarter.

Golden Deeps Ltd reports outstanding high-grade copper, silver, and critical metals results from its Central Otavi Project in Namibia, alongside a $3.54 million capital raise to fund ongoing exploration.

Ovanti Limited advances its U.S. buy now, pay later ambitions through strategic partnerships and a proposed Nasdaq listing valued at US$300 million.

Alicanto Minerals has secured a transformative acquisition of the Mt Henry Gold Project in Western Australia, backed by a $28 million capital raise and a strategic partnership with Westgold. This move sets the stage for a major resource expansion and leadership refresh.

Minbos Resources Limited reported a challenging quarter with significant cash outflows but plans a $1 million share purchase plan to bolster its funding position.

Tissue Repair’s December quarter update reveals a cautious path forward for its Phase 3 TR987 trial amid slow patient recruitment, while its TR Pro+ product line gains momentum through a new distributor partnership and upcoming product launches.

RBR Group Limited reports a significant uptick in tender opportunities exceeding US$80 million following the restart of major LNG projects in Mozambique, alongside steady contract revenues and ongoing infrastructure investments.

Recce Pharmaceuticals progresses its Phase 3 diabetic foot infection trial in Indonesia, reports promising preclinical data for inhaled RECCE 327, and secures significant R&D funding and patent protection.

Identitii Limited has secured five new customer contracts worth $250k and seen a four-fold increase in usage of its BNDRY platform, even as its capital raising efforts face delays due to a Takeovers Panel application.